The results revealed moderate positive correlations between the expression of CXCR4 with that of PD-L1 (CD274) or CTLA4 in GC, which, in some ways, may be exploited for improving the efficacy of immunotherapy. The gene discussed is CTLA4; the disease is gastric cancer.